TL;DR
Compounding pharmacy accreditation is an independent review of a named facility against defined standards. It can add useful evidence, but it should not be treated as proof that every medication is safe, effective, or free from error. We recommend reviewing the credential’s scope and status alongside current licensing, inspection, facility, and prescription records.
What compounding pharmacy accreditation means
Accreditation is generally an independent evaluation against recognized standards. The review applies to a defined organization, activity, location, and period rather than every future action the organization may take.
Accreditation programs may use self-assessment, document review, peer review, or other evaluation methods. The exact process depends on the accrediting body, so we recommend checking:
- Who issued the credential
- The facility’s exact legal name and address
- The activities covered by the credential
- Its current status
- Its issue and expiration dates
What accreditation can show
A current accreditation record can show that an accreditor evaluated a facility against its program standards. It may provide evidence of documented procedures, quality controls, or a commitment to continuing review.
The scope matters. A credential for one entity, location, or service should not automatically be applied to another. We rely on the accreditor’s current directory where possible rather than a logo displayed on a pharmacy website.
What accreditation does not prove
An accreditation badge does not provide a guarantee for every prescription or dose. It also does not answer every question about licensing, inspections, product handling, or a medication’s regulatory status.
For that reason, we treat accreditation as one part of a broader review. Current primary records carry more weight than an undated seal or an unsupported claim that a pharmacy is “fully approved.”
State licenses, NABP accreditation, and FDA registration are not the same
Terms such as “licensed,” “accredited,” “registered,” and “approved” describe different records. They should not be used interchangeably.
| Record | What to verify | Main limitation |
|---|---|---|
| Facility license | Legal name, address, status, restrictions, and expiration | Applies to the listed entity and location |
| Nonresident permit | State, status, scope, and expiration | Does not replace other required credentials |
| Pharmacist license | Individual’s name, jurisdiction, and status | Does not accredit the facility |
| Compounding accreditation | Accreditor, scope, location, status, and dates | Does not guarantee every medication |
| FDA facility record | Facility name, category, and current listing | Does not by itself establish product approval |
| Product approval record | Exact drug and application information | Is separate from pharmacy accreditation |
Requirements vary by jurisdiction and activity. When we review a pharmacy, we look for the records relevant to the facility and the state connected with the prescription.
State board licenses and nonresident permits
State board databases can help confirm a pharmacy’s legal name, address, credential status, and any published restrictions or disciplinary actions. Similar trading names may refer to different legal entities, so exact matching matters.
A practical review may include:
- The facility’s license and status
- Relevant permits for dispensing across state lines
- Published restrictions or disciplinary orders
- The dates shown in the official record
NABP Compounding Pharmacy Accreditation and former PCAB accreditation
A pharmacy may describe its credential as NABP Compounding Pharmacy Accreditation or refer to PCAB, an older term still found on some websites and seals. We recommend checking the responsible organization’s current directory rather than relying on historical branding.
The directory record should match the facility that compounds or dispenses the medication. Accreditation remains separate from licenses, permits, and government records.
FDA registration does not mean FDA approval
A facility’s appearance in an FDA record should be interpreted according to that record’s stated purpose. Facility registration and product approval are separate concepts, and neither should be inferred from the other.
The distinction is especially relevant when reviewing compound tirzepatide access, safety, and refill rules. We recommend confirming the medication, facility, prescription, and current regulatory information rather than relying on broad marketing language.
503A pharmacies and 503B outsourcing facilities follow different frameworks
The terms 503A and 503B refer to different federal compounding frameworks. Their requirements are not interchangeable, and the applicable rules may depend on the facility’s activities and the circumstances surrounding the prescription.
We want patients to know which organization compounded the medication, which one dispensed it, and where each activity occurred.
What section 503A means
Facilities operating under the section 503A framework are commonly associated with patient-specific prescription compounding. State and federal requirements may both be relevant, depending on the activity and location.
A label such as “503A pharmacy” is not enough for our review. We still check the facility’s identity, available credentials, and published records.
What section 503B means
Section 503B provides a framework for facilities that elect to operate as outsourcing facilities. Registration should be confirmed through the relevant current record, along with the exact facility name and address.
That status should not be presented as approval of every medication produced by the facility.
Questions to ask about the facility
We recommend asking:
- Who compounded the medication?
- Where was it compounded?
- Which framework did the facility use for this service?
- Who dispensed and shipped the prescription?
- Which current public records apply to those entities?
Standards and records that add context beyond accreditation
No single document gives a complete view of a compounding operation. Accreditation, inspection results, disciplinary files, testing records, sourcing controls, and shipping procedures answer different questions.
USP standards used in compounding
Pharmacies may cite USP standards when describing nonsterile, sterile, or hazardous-drug compounding. A reference to a standard does not, on its own, demonstrate that a particular facility complies with every relevant requirement.
We look for context: which activity the standard covers, how the pharmacy documents its procedures, and which authority applies it.
Inspection and discipline records
Inspection and disciplinary records can reveal findings, restrictions, corrective actions, or changes in status. A completed inspection should not be described as a clean inspection unless the published record supports that conclusion.
Older records also require context. They may be relevant, but they do not automatically describe current operations.
Testing, sourcing, storage, and shipping policies
Testing terms can sound reassuring while answering only a narrow question. We look for the type of test, the material or product tested, the responsible laboratory, and how the result relates to the dispensed medication.
Storage and shipping procedures also matter, particularly for temperature-sensitive products. Packaging, transit time, handling instructions, and complaint reporting should be clear enough for patients to follow.
How temi chooses compounding pharmacies
At temi, we believe “trusted pharmacy” should be supported by documented review rather than marketing language. Our criteria must reflect checks our team actually performs and records we can verify.
No vetting process can remove every medication or delivery risk.
Initial pharmacy review
Our review may consider the facility’s identity, relevant licenses, accreditation claims, public inspection or disciplinary records, compounding framework, sourcing information, and shipping procedures.
We do not present a criterion as confirmed unless our operations team has documented its scope and source. If we cannot verify a claim, we remove or qualify it.
Ongoing credential monitoring
A one-time review can become outdated. Credentials expire, ownership changes, regulators publish new records, and recalls may affect particular products or lots.
Our monitoring process should therefore identify what changed, which facility or medication is affected, and what action is supported by our approved procedures.
What temi should disclose to patients
Patients should be able to identify the dispensing pharmacy and find its contact details on their prescription materials. They also need a clear route for reporting package damage, suspected quality problems, side effects, and recall concerns.
People using temi to keep their medications in one place still need to retain accurate labels, prescription records, and pharmacy information.
What to check when your compounded medication arrives
We recommend checking the label and package before the first dose. If the instructions, seal, temperature, or appearance causes concern, pause and contact the dispensing pharmacy or prescribing team.
Read the prescription label
Confirm the available details, including:
- Patient and medication names
- Strength, dose, route, and directions
- Dispensing pharmacy details
- Storage instructions
- Beyond-use or discard information
- Lot or other identifying information, when provided
Do not guess if the label differs from the care plan.
Inspect the package
Check for leaks, broken seals, damage, unexpected particles, or missing supplies. For products shipped with temperature controls, follow the pharmacy’s written handling instructions.
Keep the carton, label, tracking information, and photographs if something looks wrong.
Report a problem
Contact the pharmacy about dispensing, packaging, or product-quality concerns. Clinical questions, including side effects and dosing, should go to the prescribing team. Seek urgent medical care for severe symptoms.
Our prescription refill support team can help identify the appropriate contact, but it does not replace a pharmacist, prescriber, or emergency service.
What happens after a license lapse, inspection finding, or recall
A license lapse, restriction, inspection finding, warning, and recall are not equivalent. Each record must be read according to its scope.
A credential expires or becomes restricted
We first verify the change with the issuing organization. We then identify the affected legal entity, location, service, and jurisdiction before deciding what action is supported.
An inspection finds a problem
An inspection finding should be reviewed with the facility’s response, any corrective action, and the current record. It should not automatically be described as a recall or closure.
A medication is recalled
Recall instructions usually identify the affected medication, company, lot, or date range. Patients should compare those details with the package and contact the pharmacy or care team.
We recommend keeping the medication and records until an appropriate professional provides return or disposal instructions.
Compounding pharmacy accreditation questions
What accreditation should a compounding pharmacy have?
There is no single answer for every facility. The relevant credential depends on the services, location, governing rules, and accrediting program. We start with current official records, then assess accreditation within its stated scope.
What is NABP accreditation?
NABP is an organization associated with pharmacy-related programs, including accreditation services. If a pharmacy claims NABP accreditation, verify the legal name, address, scope, status, and dates in the current directory.
Is PCAB accreditation still a current term?
PCAB may appear in older references to compounding accreditation. A historical seal does not establish current status, so we recommend checking the present program and directory entry.
What do AACSB and PHAB accreditation mean?
AACSB relates to business education, while PHAB relates to public health departments. Neither should be treated as compounding pharmacy accreditation. Always check what organization, service, and standards a credential actually covers.
FAQ
Is an accredited compounding pharmacy automatically safe?
No credential can guarantee every prescription or remove all risk. Accreditation is one source of evidence that should be considered with current facility, licensing, inspection, and medication records.
Are compounded GLP-1 medications FDA-approved?
Do not infer a medication’s approval status from a pharmacy credential or facility registration. Check current FDA information for the exact product and discuss the prescribed medication with the pharmacist or prescriber.
How can I verify a compounding pharmacy?
Search official directories using the exact legal name and address. Compare the facility’s license, accreditation claim, listed location, relevant permits, and published restrictions. Confirm that each record is current.
What should I do if my medication arrives warm or damaged?
Do not use it until the dispensing pharmacy or prescribing team provides instructions. Save the package, label, tracking details, and photographs. Seek urgent care if severe symptoms occur.
Get help with your prescription
Use temi prescription support to identify the dispensing pharmacy, review refill details, or find the right contact for a prescription or package concern.
